Clinical Trials on Persons With Frontal Lobe Damage With no Specific Language Disorder in Canada
Totalt 0 resultater
Ingenting funnet
Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.
Sponsorer og samarbeidspartnere
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Alfred Hospital Intensive Care Unit Australia
- Stefania Basili
- Jikei University School of Medicine
- Delosis Limited
- RINO ZUID
- InfraScan, Inc.
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Canadian Hemophilia Society
- Shamir Optical Industry Ltd
- Research Unit of General Practice, Odense
- The First Affiliated Hospital of Air Force Medicial University
- Donna Hammond, PhD
- Jiajie Chen
- IDRI Corporation
- Centre Hospitalier de Bastia
- Deutsche Arthrose-Hilfe
- Prof. Jürgen Kuschyk, M.D
- University of Natural Resources and Life Sciences, Vienna, Austria
- Vis full liste
Medisinsk tilstand
- Pankreatobiliær sykdom
- Respiratorisk distress syndrom, pediatrisk
- Sigdcellesår
- BK Viremia
- Febril
- Terapierelatert MDS
- Pneumonektomi; Status
- Den koagulolytiske balansen
- Homocystinuri på grunn av cystationin beta-syntase-mangel
- Faryngitt, smittsom
- Kronisk kløe av ukjent opprinnelse
- Pulmonal arteriovenøse misdannelser
- Traumetannlege
- Gangart, spastisk
- Patologisk brudd, høyre lårben
- CaIMR
- Diarésykdom, smittsom
- Kreftoverlevende med historie med antracyklinkjemoterapi
- Inotrope midler
- Stage IVA Laryngeal Verrucous Carcinoma
- Vis full liste
Legemiddelintervensjoner
- Rosuvastatin kalsiumtabletter
- Gemcitabin (mg/m²)
- INCB7839
- Domperidon
- Hypertonisk saltvann
- HLX23
- Nanoliposomalt irinotekan
- JR-141
- 13 valent pneumokokkkonjugatvaksine og 23 valent pneumokokkpolysakkaridvaksine
- LIS 18 U
- Moxifloxacin
- Arm 1 - GEH120714 (18F) Injeksjon
- Epoetin beta (NeoRecormon®)
- Klorcyklizin HCl
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Radioligand (11C)AZD2184
- Sorafenib og OSI-906
- Prukaloprid
- Atorvastatin, 10 mg, 20 mg, 40 mg
- Vis full liste
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Chile
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Finland
- Contract Research Organizations in Ireland
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Morocco
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Oman
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Türkiye
- CRO list by country